Novel and recurrent ACADS mutations and clinical manifestations observed in korean patients with short-chain Acyl-coenzyme a dehydrogenase deficiency

Yoo Mi Kim, Chong Kun Cheon, Kyung Hee Park, Sung Won Park, Gu Hwan Kim, Han Wook Yoo, Kyunga Lee, Jung Min Ko

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Short-chain acyl-CoA dehydrogenase (SCAD) catalyzes the first step in mitochondrial shortchain β-oxidation, and its deficiency is caused by mutations in the ACADS. We sought to investigate the spectrum ACADS mutations and associated clinical manifestations in Korean patients with SCAD deficiency. The study included ten patients with SCAD deficiency from 8 unrelated families as diagnosed by biochemical profile and mutation analyses. Clinical features, biochemical data, growth, and neurodevelopmental state were reviewed retrospectively. Eight patients were found during newborn screening, and two were diagnosed by family screening. During follow-up ranging from 2 months to 4.5 years, no hypoglycemic event was noted, and the development and growth of the patients were normal, except in two siblings. One exhibited hypotonia and gross motor delay, while one girl showed cyclic vomiting until the age of two years. We identified seven different mutations of ACADS. Of these, p.E344G was the most frequent mutation with an allele frequency of 50%, followed by p.P55L with 18.8%. p.G108D and four novel mutations were identified: p.L93I, p.E228K, p.P377L, and p.R386H. Korean patients with SCAD deficiency showed heterogenous clinical features and ACADS genotype. Our data contributes to a better understanding of the distinct molecular genetic characteristics and clinical manifestations of SCAD deficiency.

Original languageEnglish
Pages (from-to)360-366
Number of pages7
JournalAnnals of Clinical and Laboratory Science
Volume46
Issue number4
Publication statusPublished - 2016 Jan 1

Fingerprint

Butyryl-CoA Dehydrogenase
Coenzymes
Oxidoreductases
Mutation
Screening
Muscle Hypotonia
Hypoglycemic Agents
Growth and Development
Gene Frequency
Vomiting
Siblings
Molecular Biology
Oxidation
Genotype
Newborn Infant
Short chain Acyl CoA dehydrogenase deficiency
Growth

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology
  • Molecular Biology
  • Hematology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

Kim, Yoo Mi ; Cheon, Chong Kun ; Park, Kyung Hee ; Park, Sung Won ; Kim, Gu Hwan ; Yoo, Han Wook ; Lee, Kyunga ; Ko, Jung Min. / Novel and recurrent ACADS mutations and clinical manifestations observed in korean patients with short-chain Acyl-coenzyme a dehydrogenase deficiency. In: Annals of Clinical and Laboratory Science. 2016 ; Vol. 46, No. 4. pp. 360-366.
@article{9280b0b555bf4c809ca400878a2e5a97,
title = "Novel and recurrent ACADS mutations and clinical manifestations observed in korean patients with short-chain Acyl-coenzyme a dehydrogenase deficiency",
abstract = "Short-chain acyl-CoA dehydrogenase (SCAD) catalyzes the first step in mitochondrial shortchain β-oxidation, and its deficiency is caused by mutations in the ACADS. We sought to investigate the spectrum ACADS mutations and associated clinical manifestations in Korean patients with SCAD deficiency. The study included ten patients with SCAD deficiency from 8 unrelated families as diagnosed by biochemical profile and mutation analyses. Clinical features, biochemical data, growth, and neurodevelopmental state were reviewed retrospectively. Eight patients were found during newborn screening, and two were diagnosed by family screening. During follow-up ranging from 2 months to 4.5 years, no hypoglycemic event was noted, and the development and growth of the patients were normal, except in two siblings. One exhibited hypotonia and gross motor delay, while one girl showed cyclic vomiting until the age of two years. We identified seven different mutations of ACADS. Of these, p.E344G was the most frequent mutation with an allele frequency of 50{\%}, followed by p.P55L with 18.8{\%}. p.G108D and four novel mutations were identified: p.L93I, p.E228K, p.P377L, and p.R386H. Korean patients with SCAD deficiency showed heterogenous clinical features and ACADS genotype. Our data contributes to a better understanding of the distinct molecular genetic characteristics and clinical manifestations of SCAD deficiency.",
author = "Kim, {Yoo Mi} and Cheon, {Chong Kun} and Park, {Kyung Hee} and Park, {Sung Won} and Kim, {Gu Hwan} and Yoo, {Han Wook} and Kyunga Lee and Ko, {Jung Min}",
year = "2016",
month = "1",
day = "1",
language = "English",
volume = "46",
pages = "360--366",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "4",

}

Novel and recurrent ACADS mutations and clinical manifestations observed in korean patients with short-chain Acyl-coenzyme a dehydrogenase deficiency. / Kim, Yoo Mi; Cheon, Chong Kun; Park, Kyung Hee; Park, Sung Won; Kim, Gu Hwan; Yoo, Han Wook; Lee, Kyunga; Ko, Jung Min.

In: Annals of Clinical and Laboratory Science, Vol. 46, No. 4, 01.01.2016, p. 360-366.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel and recurrent ACADS mutations and clinical manifestations observed in korean patients with short-chain Acyl-coenzyme a dehydrogenase deficiency

AU - Kim, Yoo Mi

AU - Cheon, Chong Kun

AU - Park, Kyung Hee

AU - Park, Sung Won

AU - Kim, Gu Hwan

AU - Yoo, Han Wook

AU - Lee, Kyunga

AU - Ko, Jung Min

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Short-chain acyl-CoA dehydrogenase (SCAD) catalyzes the first step in mitochondrial shortchain β-oxidation, and its deficiency is caused by mutations in the ACADS. We sought to investigate the spectrum ACADS mutations and associated clinical manifestations in Korean patients with SCAD deficiency. The study included ten patients with SCAD deficiency from 8 unrelated families as diagnosed by biochemical profile and mutation analyses. Clinical features, biochemical data, growth, and neurodevelopmental state were reviewed retrospectively. Eight patients were found during newborn screening, and two were diagnosed by family screening. During follow-up ranging from 2 months to 4.5 years, no hypoglycemic event was noted, and the development and growth of the patients were normal, except in two siblings. One exhibited hypotonia and gross motor delay, while one girl showed cyclic vomiting until the age of two years. We identified seven different mutations of ACADS. Of these, p.E344G was the most frequent mutation with an allele frequency of 50%, followed by p.P55L with 18.8%. p.G108D and four novel mutations were identified: p.L93I, p.E228K, p.P377L, and p.R386H. Korean patients with SCAD deficiency showed heterogenous clinical features and ACADS genotype. Our data contributes to a better understanding of the distinct molecular genetic characteristics and clinical manifestations of SCAD deficiency.

AB - Short-chain acyl-CoA dehydrogenase (SCAD) catalyzes the first step in mitochondrial shortchain β-oxidation, and its deficiency is caused by mutations in the ACADS. We sought to investigate the spectrum ACADS mutations and associated clinical manifestations in Korean patients with SCAD deficiency. The study included ten patients with SCAD deficiency from 8 unrelated families as diagnosed by biochemical profile and mutation analyses. Clinical features, biochemical data, growth, and neurodevelopmental state were reviewed retrospectively. Eight patients were found during newborn screening, and two were diagnosed by family screening. During follow-up ranging from 2 months to 4.5 years, no hypoglycemic event was noted, and the development and growth of the patients were normal, except in two siblings. One exhibited hypotonia and gross motor delay, while one girl showed cyclic vomiting until the age of two years. We identified seven different mutations of ACADS. Of these, p.E344G was the most frequent mutation with an allele frequency of 50%, followed by p.P55L with 18.8%. p.G108D and four novel mutations were identified: p.L93I, p.E228K, p.P377L, and p.R386H. Korean patients with SCAD deficiency showed heterogenous clinical features and ACADS genotype. Our data contributes to a better understanding of the distinct molecular genetic characteristics and clinical manifestations of SCAD deficiency.

UR - http://www.scopus.com/inward/record.url?scp=84994138762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994138762&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 360

EP - 366

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 4

ER -